Calculator
A New Red Fluorescent & Robust Screen Quest™ Rhod-4™ Ca2+Indicator for Screening GPCR & Ca2+ Channel Targets
by Jianjun He, Wenping Chang, Zhenjun Diwu, Jinfiang Liao
Calcium flux assays are preferred methods in drug discovery for screening G protein coupled receptors (GPCRs). Although Rhod-2 has been the most popular red fluorescent Ca2+ indicator for minimizing the compounds' auto-fluorescence interference. In addition, its mitochondrial localization and high basal Ca2+ signal in cells have severely limited its cellular applications. Finally the less optimal excitation of Rhod-2 at 488 nm makes it less robust to use with some instruments that have only 488 nm excitation light source. Our Rhod-4™ serial calcium detection reagents have been developed to address these limitations of Rhod-2. It is quite unique that Rhod-4™ can be well excited with an argon ion laser at 488 nm besides its 514 nm, 532 nm, 546 nm excitations. The characteristics of its predominantly cytosol localization, and long multi-wavelength excitation and >100 times fluorescence enhancement (when it forms a complex with calcium) make Rhod-4™ an ideal indicator for measurement of cellular calcium especially when the library compounds have strong fluorescence and the applications require GFP. Our Rhod-4™ AM is more than 4 fold brighter than Rhod-2 AM in cells. This characteristic makes Rhod-4™ more robust for HTS applications.
CHO-M1 or HEK cells were plated in a 96-well black wall/clear bottom costar plate and stored at 37°C overnight in an incubator.
Rhod-4™ AM is optimized for a broad range of instruments to give maximum performance with GPCR and calcium channel targets. Rhod-4™ AM calcium reagents have the following benefits:
Original created on November 20, 2019, last updated on November 20, 2019
Tagged under:
Introduction
Screen Quest™ Rhod-4 Calcium Assay
Materials and Method
CHO-M1 or HEK cells were plated in a 96-well black wall/clear bottom costar plate and stored at 37°C overnight in an incubator.
- Take growth medium off (if cells were plating in 0.5-1% FBS, skip this step), incubate the cells with Rhod-4 AM or Rhod-2 AM at room temperature for 1-2 h (or at 37°C for 1 h, then at room temperature for 30 min).
- For wash experiments: wash cells with HHBS buffer twice, then replace with HHBS buffer.
- For No wash experiments: run the experiments directly.
- Run calcium efflux experiments on NOVOstar (BMG Labtec) at Ex/Em = 530/570 nm.
method
Results
UsOS cells were seeded overnight at 40,000 cells per 100 µL per well in a 96 well black wall/clear bottom costar plate. The growth medium was removed, and the cells were incubated with 100 µL of 5 µM Rhod-4 AM or Rhod-2 AM in HHBS at 37°C for 1 hour. The cells were washed twice with 200 µL HHBS, then imaged with a fluorescence microscope (Olympus IX71) using FITC channel.
Comparisons of Rhod-4™ AM and Rhod-2 AM in HEK-293 cells. HEK-293 cells were seeded overnight in 40,000 cells per 100 µL per well in a 96-well black wall/clear bottom costar plate. The growth medium was removed, and the cells were incubated with 100 µL of 5 µM Rhod-4AM or Rhod-2AM in HHBS at 37°C for 1hr.Then wash the cells with 2 times of HHBS. 30 µM of Carbachol 50 µL/well) was added by NOVOstar (BMB Labtech).
Carbachol Dose Response in HEK-293 cells. HEK-293 cells were seeded overnight at 40,000 cells per 100 µL per well in a 96-well black wall/clear bottom plate. The growth medium was removed, and the cells were incubated with 100 µL of Rhod-4™ NW Calcium assay kit, or 5 µM Rhod-2 AM at 37°C, 5% CO2 incubator for 1 hour. Carbachol (25 µL/well) was added by NOVOstar to achieve the final indicated concentrations. The EC50 is 0.8 µM which is similar as reported.
ATP dose response in CHO-K1 Cells. CHO-K1 cells were seeded overnight at 60,000 cells/100 µL/well in a 96-well black wall/clear bottom Costar plate. The growth medium was removed and the cells were incubated with 100 µL of Rhod-4™ NW Calcium assay kit, or 5 µM Rhod-2 AM at 37°C, 5% CO2 incubator for 1 hour. Carbachol (50 µL/well) was added be NOVOstar to achieve the final indicated concentrations. The EC50 is 0.6 µM which is similar as reported.
Comparisons of Screen Quest™ Rhod-4 NW Calcium Assay Kit, Rhod-2 AM on Concanavalin A induced CA entry (capacitative calcium entry (CCE) in JurKat cells. JurKat cells were suspended at 4X106 cells per ml in calcium-free HHBS buffer, cells were incubated with equal volume of Rhod NW or Rhod-2 AM in calcium-free HHBS buffer at 2X105 cells/well/100 µL at a 96-well black wall/clear bottom costar plate for 1 hr at 37°C, 5% CO2 incubator. At the end of the 10 min incubation, the channel opener Concanavalin A at 1 µg/ml with or without the channel inhibitor SKF96365 at 30 µM were added into the cells. 50 µL/well of HBSS with additional 24 mM (5X) calcium (so final in well concentration of calcium is 5 mM) was added by NOVOstar (BMG Labtech).
Summary
Rhod-4™ AM is optimized for a broad range of instruments to give maximum performance with GPCR and calcium channel targets. Rhod-4™ AM calcium reagents have the following benefits:
- Cytosol Localization: Quest™ Rhod-4 AM is predominantly localized in cytosol while Rhod-2 AM is localized in mitochondira
- Multiple Excitation Options @ ~490 nm, 514 nm, 532 nm and 546 nm
- Much Larger Assay Window: 10 times better than Rhod-2 AM
- More Signal: 4 times brighter than Rhod-2 AM at Ex 530 nm/Em 570 nm
Product Ordering Information
Table 1. Red Fluorescent Calcium Indicators
| Cat No. ▲ ▼ | Prduct Name ▲ ▼ | Unit Size ▲ ▼ |
| 20451 | Rhod-2 dextran conjugate *Low affinity with MW 10,000* | 1 mg |
| 21060 | Rhod-2, AM *CAS#: 145037-81-6* | 1 mg |
| 21062 | Rhod-2, AM *UltraPure Grade* *CAS#: 145037-81-6* | 1 mg |
| 21063 | Rhod-2, AM *UltraPure Grade* *CAS#: 145037-81-6* | 50 mg |
| 21064 | Rhod-2, AM *UltraPure Grade* *CAS#: 145037-81-6* | 20x50 µg |
| 21067 | Rhod-2, tripotassium salt | 1 mg |
| 21068 | Rhod-2, trisodium salt | 1 mg |
| 21070 | Rhod-2, trisodium salt | 1 mg |
| 21072 | Rhod-5N, tripotassium salt | 1 mg |
| 21075 | Rhod-FF, tripotassium salt | 1 mg |
Original created on November 20, 2019, last updated on November 20, 2019
Tagged under: